{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-017504","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.251752+00:00","generated_at":"2026-06-01T15:04:01.616033+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Jury awards Puma/Wyeth $107.5M in Tagrisso patent infringement case vs AstraZeneca","bullets":["Jury found '314 and '162 patents infringed and not invalid; damages $107.5M for past acts.","Puma was dismissed as plaintiff but retains contractual right to recover damages under Pfizer license.","Bench trial on equitable defenses (unclean hands, patent misuse) set for June 17-18, 20, 2024.","Further proceedings will determine ongoing royalty rate through patent term."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-017504","json":"https://secwatch.observer/filing/0001437749-24-017504.json","markdown":"https://secwatch.observer/filing/0001437749-24-017504.md","text":"https://secwatch.observer/filing/0001437749-24-017504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924017504/0001437749-24-017504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924017504/pbyi20240517_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T15:04:01.616033+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}